Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Duration of challenge immunity to coronavirus JHM in mice

Identifieur interne : 001491 ( Main/Exploration ); précédent : 001490; suivant : 001492

Duration of challenge immunity to coronavirus JHM in mice

Auteurs : S. W. Barthold [États-Unis] ; Abigail L. Smith [États-Unis]

Source :

RBID : ISTEX:0A92D565FBC57699E16D52F3EC7499CD1AFA1349

Descripteurs français

English descriptors

Abstract

Summary: The duration of challenge resistance in mice immunized with mouse hepatitis virus (MHV) strain JHM was examined as a model of immunity to corona-virus infection. Genetically susceptible BALB/cByJ mice were immunized by intranasal (i.n.) or per os (p.o.) inoculation with MHV-JHM or sterile tissue culture fluid (sham) then challenged i.n. with MHV-JHM or sterile tissue culture fluid 1, 6, or 12 months later. Four days after challenge, virus in nasal turbinates and liver was quantified, and prevalance of microscopic lesions in liver and gut-associated lymphoid tissue was tabulated as indices of challenge resistance. MHV-immunized and challenged groups were compared to sham-immunized and challenged groups. Mice immunized by i.n. inoculation were strongly resistant to challenge at 1, 6, and 12 months. Mice immunized by p.o. inoculation were resistant at 1 month, but became partially susceptible to reinfection at 6 and 12 months, based upon all indices. These data indicate that, depending upon route of immunization, mice can become susceptible to reinfection with the same coronavirus strain over time.

Url:
DOI: 10.1007/BF01317914


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Duration of challenge immunity to coronavirus JHM in mice</title>
<author>
<name sortKey="Barthold, S W" sort="Barthold, S W" uniqKey="Barthold S" first="S. W." last="Barthold">S. W. Barthold</name>
</author>
<author>
<name sortKey="Smith, Abigail L" sort="Smith, Abigail L" uniqKey="Smith A" first="Abigail L." last="Smith">Abigail L. Smith</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0A92D565FBC57699E16D52F3EC7499CD1AFA1349</idno>
<date when="1989" year="1989">1989</date>
<idno type="doi">10.1007/BF01317914</idno>
<idno type="url">https://api.istex.fr/ark:/67375/1BB-4BD0PJDZ-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000176</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000176</idno>
<idno type="wicri:Area/Istex/Curation">000156</idno>
<idno type="wicri:Area/Istex/Checkpoint">000635</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000635</idno>
<idno type="wicri:doubleKey">0304-8608:1989:Barthold S:duration:of:challenge</idno>
<idno type="wicri:Area/Main/Merge">001512</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:90-0072389</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000068</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000062</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000067</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000067</idno>
<idno type="wicri:doubleKey">0304-8608:1989:Barthold S:duration:of:challenge</idno>
<idno type="wicri:Area/Main/Merge">001519</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:2554852</idno>
<idno type="wicri:Area/PubMed/Corpus">000745</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000745</idno>
<idno type="wicri:Area/PubMed/Curation">000745</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000745</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000734</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000734</idno>
<idno type="wicri:Area/Ncbi/Merge">000428</idno>
<idno type="wicri:Area/Ncbi/Curation">000428</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000428</idno>
<idno type="wicri:doubleKey">0304-8608:1989:Barthold S:duration:of:challenge</idno>
<idno type="wicri:Area/Main/Merge">001497</idno>
<idno type="wicri:Area/Main/Curation">001491</idno>
<idno type="wicri:Area/Main/Exploration">001491</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Duration of challenge immunity to coronavirus JHM in mice</title>
<author>
<name sortKey="Barthold, S W" sort="Barthold, S W" uniqKey="Barthold S" first="S. W." last="Barthold">S. W. Barthold</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Section of Compariative Medicine, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName>
<region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Smith, Abigail L" sort="Smith, Abigail L" uniqKey="Smith A" first="Abigail L." last="Smith">Abigail L. Smith</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Section of Compariative Medicine, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName>
<region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Archives of Virology</title>
<title level="j" type="abbrev">Archives of Virology</title>
<idno type="ISSN">0304-8608</idno>
<idno type="eISSN">1432-8798</idno>
<imprint>
<publisher>Springer-Verlag</publisher>
<pubPlace>Vienna</pubPlace>
<date type="published" when="1989-09-01">1989-09-01</date>
<biblScope unit="volume">107</biblScope>
<biblScope unit="issue">3-4</biblScope>
<biblScope unit="page" from="171">171</biblScope>
<biblScope unit="page" to="177">177</biblScope>
</imprint>
<idno type="ISSN">0304-8608</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0304-8608</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animal model</term>
<term>Animals</term>
<term>Antibodies, Viral (analysis)</term>
<term>Comparative study</term>
<term>Immune response</term>
<term>Immunity</term>
<term>Immunization</term>
<term>Intestines (immunology)</term>
<term>Intestines (pathology)</term>
<term>Liver (microbiology)</term>
<term>Liver (pathology)</term>
<term>Lymphoid Tissue (pathology)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Mouse</term>
<term>Murine coronavirus</term>
<term>Murine hepatitis virus</term>
<term>Murine hepatitis virus (immunology)</term>
<term>Murine hepatitis virus (isolation & purification)</term>
<term>Nasal Bone (microbiology)</term>
<term>Random Allocation</term>
<term>Reinfection</term>
<term>Resistance</term>
<term>Respiratory disease</term>
<term>Route of administration</term>
<term>Sensitivity</term>
<term>Strain</term>
<term>Time Factors</term>
<term>Viral disease</term>
<term>Virus multiplication</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Anticorps antiviraux (analyse)</term>
<term>Attribution aléatoire</term>
<term>Facteurs temps</term>
<term>Foie (anatomopathologie)</term>
<term>Foie (microbiologie)</term>
<term>Immunité</term>
<term>Intestins (anatomopathologie)</term>
<term>Intestins (immunologie)</term>
<term>Os nasal (microbiologie)</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Tissu lymphoïde (anatomopathologie)</term>
<term>Virus de l'hépatite murine (immunologie)</term>
<term>Virus de l'hépatite murine (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Foie</term>
<term>Intestins</term>
<term>Tissu lymphoïde</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Intestins</term>
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Intestines</term>
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr">
<term>Foie</term>
<term>Os nasal</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Liver</term>
<term>Nasal Bone</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Intestines</term>
<term>Liver</term>
<term>Lymphoid Tissue</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Immunity</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Random Allocation</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Animaux</term>
<term>Appareil respiratoire pathologie</term>
<term>Attribution aléatoire</term>
<term>Coronavirus murin</term>
<term>Etude comparative</term>
<term>Facteurs temps</term>
<term>Immunisation</term>
<term>Immunité</term>
<term>Modèle animal</term>
<term>Multiplication virus</term>
<term>Réinfection</term>
<term>Réponse immune</term>
<term>Résistance</term>
<term>Sensibilité</term>
<term>Souche</term>
<term>Souris</term>
<term>Souris BALB/c</term>
<term>Souris de lignée BALB C</term>
<term>Tissu lymphoïde associé intestin</term>
<term>Virose</term>
<term>Virus hépatite murine</term>
<term>Voie administration</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Absolute challenge resistance</term>
<term>Antibody titers</term>
<term>Arch virol</term>
<term>Barthold</term>
<term>Brain infection</term>
<term>Challenge immunity</term>
<term>Challenge infection</term>
<term>Challenge resistance</term>
<term>Comparative medicine</term>
<term>Coronavirus</term>
<term>Detectable liver virus</term>
<term>Detectable virus</term>
<term>Experimental mice</term>
<term>Galt</term>
<term>High prevalence</term>
<term>High titers</term>
<term>Immunization</term>
<term>Immunizing infection</term>
<term>Infection</term>
<term>Inoculation</term>
<term>Inoculation results</term>
<term>Intranasal</term>
<term>Intranasal challenge inoculation</term>
<term>Intranasal inoculation</term>
<term>Lesion</term>
<term>Lymphoid tissue</term>
<term>Month interval</term>
<term>Mouse</term>
<term>Mouse hepatitis virus</term>
<term>Nasal</term>
<term>Nasal mucosa</term>
<term>Nasal turbinates</term>
<term>Olfactory mucosa</term>
<term>Rodent coronaviruses</term>
<term>Same coronavirus strain</term>
<term>Sentinel mice</term>
<term>Serum antibody</term>
<term>Sham</term>
<term>Sham inoculation</term>
<term>Shamimmunized mice</term>
<term>Sterile tissue culture fluid</term>
<term>Susceptible mice</term>
<term>Tissue culture fluid</term>
<term>Titer</term>
<term>Treatment groups</term>
<term>Turbinate</term>
<term>Virus strainspecific</term>
<term>Yale university school</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Summary: The duration of challenge resistance in mice immunized with mouse hepatitis virus (MHV) strain JHM was examined as a model of immunity to corona-virus infection. Genetically susceptible BALB/cByJ mice were immunized by intranasal (i.n.) or per os (p.o.) inoculation with MHV-JHM or sterile tissue culture fluid (sham) then challenged i.n. with MHV-JHM or sterile tissue culture fluid 1, 6, or 12 months later. Four days after challenge, virus in nasal turbinates and liver was quantified, and prevalance of microscopic lesions in liver and gut-associated lymphoid tissue was tabulated as indices of challenge resistance. MHV-immunized and challenged groups were compared to sham-immunized and challenged groups. Mice immunized by i.n. inoculation were strongly resistant to challenge at 1, 6, and 12 months. Mice immunized by p.o. inoculation were resistant at 1 month, but became partially susceptible to reinfection at 6 and 12 months, based upon all indices. These data indicate that, depending upon route of immunization, mice can become susceptible to reinfection with the same coronavirus strain over time.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Connecticut</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Connecticut">
<name sortKey="Barthold, S W" sort="Barthold, S W" uniqKey="Barthold S" first="S. W." last="Barthold">S. W. Barthold</name>
</region>
<name sortKey="Smith, Abigail L" sort="Smith, Abigail L" uniqKey="Smith A" first="Abigail L." last="Smith">Abigail L. Smith</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001491 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001491 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:0A92D565FBC57699E16D52F3EC7499CD1AFA1349
   |texte=   Duration of challenge immunity to coronavirus JHM in mice
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021